Surgical treatment in bone metastases in the appendicular skeleton

• Published in: Revista española de cirugía ortopédica y traumatología 2018-05, Vol.62 (3), p.185-189
• Main Authors: Clara-Altamirano, M A, Garcia-Ortega, D Y, Martinez-Said, H, Caro-Sánchez, C H S, Herrera-Gomez, A, Cuellar-Hubbe, M
• Format: Article
• Language: eng ; spa
• ISSN: 1988-8856; 2173-576X
• DOI: 10.1016/j.recot.2017.12.001

Metastatic bone disease is the most common neoplastic process that affects the skeletal system. Eighty percent of bone metastases come from carcinomas of the breast, lung, kidney, thyroid and prostate. The Katagiri scale enables an estimation of the survival of patients based on the presence or absence of visceral metastases, multiple bone metastases and functional status according to the ECOG scale. A retrospective, descriptive and observational study conducted between March 1, 2013 and June 30, 2015. Thirty-two patients were studied with a diagnosis of metastatic bone disease and who had undergone some type of orthopaedic surgical treatment for pathological fracture or impending fracture. 28 cases (87.5%) presented pathological fracture and 4 cases (12.5%) impending fracture according to the Mirels score. Fifteen cases (46.875%) were treated by placing a central medullary nail + spacer in the long bone diaphysis, 15 cases (46.875%) with modular arthroplasties and 2 patients (6.25%) with forequarter amputation. Eleven patients (34.375%) died during the course of this study, all with a Katagiri greater than or equal to 4. The presence of a fracture in previously damaged territory is a catastrophic complication for most cancer patients. A clear understanding of the life expectancy of patients with bone metastases is of great help to prevent errors and failures in treatment.